Laser and 'Skin Booster' injection may reverse sun damage and prevent cancer

NCT ID NCT07680426

Not yet recruiting Disease control Sponsor: Bispebjerg Hospital Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether combining a fractional laser with a biostimulator (poly-L-lactic acid) can repair sun-damaged skin better than either treatment alone. The goal is to improve skin health and potentially lower the risk of skin cancer. Researchers will use AI-assisted imaging and genetic analysis to measure changes in the skin. The trial involves 33 adults with signs of chronic sun damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Poly-L-lactic acid (Sculptra)
What this could lead to: If it works, this approach could offer a non-surgical way to reverse sun damage and reduce the risk of skin cancer.
What could go wrong: This is a small, early-stage study with 33 participants, so results may not apply to everyone. Laser and injections carry risks like redness, swelling, or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHOTODAMAGED SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHOTODAMAGED SKIN SKIN CANCER PREVENTION

Contacts and locations

Locations

Bispebjerg Hospital

Copenhagen, Capital Region, 2400, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.